Shuttle Squeezes Science in Space Program

Courtesy of NASA When the space shuttle Columbia erupted into flames on re-entry, killing its crew of seven astronauts, criticism of the National Aeronautics and Space Administration grew to a fever pitch. Attackers came from all sides. Government experts wanted to know where the money was going, and science policy gurus questioned whether NASA could not better use its $15 billion (US) yearly allotment. The outcome of this debate and resultant soul-searching is especially relevant to the smal

Written bySam Jaffe
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

When the space shuttle Columbia erupted into flames on re-entry, killing its crew of seven astronauts, criticism of the National Aeronautics and Space Administration grew to a fever pitch. Attackers came from all sides. Government experts wanted to know where the money was going, and science policy gurus questioned whether NASA could not better use its $15 billion (US) yearly allotment.

The outcome of this debate and resultant soul-searching is especially relevant to the small but growing community of space scientists, those who depend on NASA for most of their funding and for access to space. In fiscal year 2002, NASA spent more than $380 million on basic research, some $150 million of it on the life sciences. To thousands of NASA grantees, talk about the future of the space program is not just about cocktail party banter; it's about salaries and careers. But agency critics warn that NASA must ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies